Agape ATP Corporation (NASDAQ:ATPC) Sees Large Drop in Short Interest

Agape ATP Corporation (NASDAQ:ATPC) was the target of a large drop in short interest during the month of June. As of June 15th, there was short interest totaling 18,792 shares, a drop of 94.0% from the May 31st total of 314,161 shares. Currently, 1.9% of the shares of the company are sold short. Based on an average daily trading volume, of 804,194 shares, the short-interest ratio is currently 0.0 days.

Analysts Set New Price Targets

A number of analysts have recently commented on the company. Weiss Ratings restated a “sell (e+)” rating on shares of Agape ATP in a research note on Friday, May 22nd. Wall Street Zen downgraded Agape ATP from a “hold” rating to a “sell” rating in a report on Sunday. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company currently has an average rating of “Sell”.

Institutional Trading of Agape ATP

A hedge fund recently raised its position in Agape ATP stock. Citadel Advisors LLC increased its holdings in shares of Agape ATP Corporation (NASDAQ:ATPC) by 95.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 65,130 shares of the company’s stock after buying an additional 31,849 shares during the period. Citadel Advisors LLC owned about 0.13% of Agape ATP worth $82,000 as of its most recent filing with the Securities and Exchange Commission (SEC). 0.01% of the stock is currently owned by hedge funds and other institutional investors.

Agape ATP Stock Down 4.8%

Shares of ATPC stock traded down $0.15 during mid-day trading on Thursday, hitting $3.00. 89,718 shares of the stock were exchanged, compared to its average volume of 7,055,344. Agape ATP has a 52-week low of $1.72 and a 52-week high of $75.25. The company has a market cap of $3 million, a PE ratio of -2.26 and a beta of 0.08. The firm has a fifty day moving average of $2.89 and a 200 day moving average of $4.28.

Agape ATP (NASDAQ:ATPC) last announced its quarterly earnings results on Friday, May 15th. The company reported ($0.33) earnings per share for the quarter. The business had revenue of $0.27 million during the quarter. Agape ATP had a negative net margin of 125.89% and a negative return on equity of 8.43%.

Agape ATP Company Profile

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement.